Pathogens move fast. Science can move faster.
Mission
Error: cannot retrieve content from CMS. Please check back later, hopefully this will be fixed! Thank you!
Show detailed error
Endpoint: https://radvac-297e5f.ingress-alpha.ewp.live/graphql Error: fetch failed
Current projects
Biofactories in a tube
Genetically-modified yeast can be used to produce and deliver proteins, some of which may help maintain the body's natural defenses.
Modernized variolation
Protocols for collecting mucus samples, inactivating viruses, and administering variolation safely. Additional protocols for decentralized sample collection and sharing.
FRIL lectin broad-spectrum antiviral
Radvac is pioneering a way to cheaply manufacture FRIL lectin from the lablab bean. FRIL is a potent broad-spectrum antiviral that can be delivered as a nasal spray or in a chewing gum formulation.
Previous projects
Nasal SARS-CoV-2 peptide vaccine
Our protocol for a peptide-conjugate intranasal vaccine, optimized across five revisions for breadth and durability against emerging SARS-CoV-2 variants.
AI for rapid drug repurposing and antiviral combinations design
Leveraging advances in open source data and AI to repurpose existing drugs and GRAS compounds as antivirals. New techniques for combining several weak antivirals into powerful combinations.
Team
Radvac is building the open infrastructure required to respond to biological threats in hours or days, not months or years.